Nov 8 (Reuters) - Sienna Cancer Diagnostics Ltd (SDX) : ENTERED INTO AGREEMENT WITH VIVAZOME THERAPEUTICS PTY LTD AGREEMENT TO ASSIST IN DEVELOPMENT OF COMMERCIAL & SCALABLE PURIFICATION PROCESS FOR VIVAZOME'S EXOSOME-BASED THERAPIES
CC9 Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings
PMT Patriot Battery Metals' early stage economic assessment boosts potential of flagship Canadian play